Tumor thickness, depth of invasion, and Bcl-2 expression are correlated with FDG-uptake in oral squamous cell carcinomas

Oral Oncology

Volumn 45, Issue 10, 2009, Pages 891-897

  Suzuki, Hidenori ^a,b   Fukuyama, Ryuichi ^a   Hasegawa, Yasuhisa ^a   Tamaki, Tsuneo ^c   Nishio, Masami ^c   Nakashima, Tsutomu ^b   Tatematsu, Masae ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c Nagoya PET Imaging Center   (Japan)

Author keywords

Bcl 2; Depth of invasion; FDG PET; Oral squamous cell carcinoma; Survival; Tumor thickness

Indexed keywords

BETA CATENIN; FLUORODEOXYGLUCOSE F 18; GLUCOSE TRANSPORTER 1; PROTEIN BCL 2; UVOMORULIN; VASCULOTROPIN; VASCULOTROPIN C;

ADULT; ARTICLE; CANCER INVASION; CARCINOGENESIS; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CARCINOMA; ORAL SQUAMOUS CELL CARCINOMA; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SURVIVAL; SURVIVAL TIME; TUMOR VOLUME;

ADULT; AGED; BETA CATENIN; CADHERINS; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE TRANSPORTER TYPE 1; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM INVASIVENESS; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIOPHARMACEUTICALS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70349156407     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2009.03.009     Document Type: Article

References (28)

1. Oriuchi N., Higuchi T., Ishikita T., et al. Present role and future prospects of positron emission tomography in clinical oncology. Cancer Sci 97 12 (2006) 1291-1297
2. Kim S.Y., Roh J.L., Kim J.S., et al. Utility of FDG PET in patients with squamous cell carcinomas of the oral cavity. Eur J Surg Oncol 34 2 (2008) 208-215
3. Kato H., Kuwano H., Nakajima M., et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer 94 4 (2002) 921-928
4. van Baardwijk A., Dooms C., van Suylen R.J., et al. The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer. Eur J Cancer 43 9 (2007) 1392-1398
5. Kato H., Takita J., Miyazaki T., et al. Correlation of 18-F-fluorodeoxyglucose (FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma. Anticancer Res 23 4 (2003) 3263-3272
6. Vansteenkiste J.F., Stroobants S.G., Dupont P.J., et al., Leuven Lung Cancer Group. Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non- small-cell lung cancer: An analysis of 125 cases. J Clin Oncol 17 10 (1999) 3201-3206
7. Liao CT, Chang JT, Wang HM, et al. Pretreatment primary tumor SUVmax measured by FDG-PET and pathologic tumor depth predict for poor outcomes in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes. Int J Radiat Oncol Biol Phys, in press.
8. Kunkel M., Reichert T.E., Benz P., et al. Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma. Cancer 97 4 (2003) 1015-1024
9. Suzuki H., Hasegawa Y., Terada A., et al. FDG-PET predicts survival and distant metastasis in oral squamous cell carcinoma. Oral Oncol 45 7 (2009) 569-573
10. Kitagawa Y., Sano K., Nishizawa S., et al. FDG-PET for prediction of tumor aggressiveness and response to intra-arterial chemotherapy and radiotherapy in head and neck cancer. Eur J Nucl Med Mol Imaging 30 1 (2003) 63-71
11. Tian M., Zhang H., Nakasone Y., Mogi K., and Endo K. Expression of Glut-1 and Glut-3 in untreated oral squamous cell carcinoma compared with FDG accumulation in a PET study. Eur J Nucl Med Mol Imaging 31 1 (2004) 5-12
12. Pentenero M., Gandolfo S., and Carrozzo M. Importance of tumor thickness and depth of invasion in nodal involvement and prognosis of oral squamous cell carcinoma: a review of the literature. Head Neck 27 12 (2005) 1080-1091
13. Goto M., Tsukamoto T., Inada K., et al. Loss of p21WAF/CIP1 expression in invasive fronts of oral tongue squamous cell carcinomas is correlated with tumor progression and poor prognosis. Oncol Rep 14 4 (2005) 837-846
14. Uehara M., Sano K., Ikeda H., et al. Expression of vascular endothelial growth factor and prognosis of oral squamous cell carcinoma. Oral Oncol 40 (2004) 321-325
15. Miyahara M., Tanuma J., Sugihara K., and Semba I. Tumor lymphangiogenesis correlates with lymph node metastasis and clinicopathologic parameters in oral squamous cell carcinoma. Cancer 110 6 (2007) 1287-1294
16. Tanaka N., Odajima T., Ogi K., Ikeda T., and Satoh M. Expression of E-cadherin, alpha-catenin, beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. BJ Cancer 89 3 (2003) 557-563
17. Macheda M.L., Rogers S., and Best J.D. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J Cell Physiol 202 3 (2005) 654-662
18. Danial N.N. BCL-2 family proteins: critical checkpoints of apoptotic cell death. Clin Cancer Res 13 24 (2007) 7254-7263
19. de Vicente J.C., Olay S., Lequerica-Fernandez P., Sánchez-Mayoral J., Junquera L.M., and Fresno M.F. Expression of Bcl-2 but not Bax has a prognostic significance in tongue carcinoma. J Oral Pathol Med 35 3 (2006) 140-145
20. Costa A., Licitra L., Veneroni S., et al. Biological markers as indicators of pathological response to primary chemotherapy in oral-cavity cancers. Int J Cancer 79 6 (1998) 619-623
21. Friedman M., Grey P., Venkatesan T.K., et al. Prognostic significance of Bcl-2 expression in localized squamous cell carcinoma of the head and neck. Ann Otol Rhinol Laryngol 106 6 (1997) 445-450
22. Takei T., Kuge Y., Zhao S., et al. Enhanced apoptotic reaction correlates with suppressed tumor glucose utilization after cytotoxic chemotherapy: use of 99m Tc-Annexin V, 18F-FDG, and histologic evaluation. J Nucl Med 46 5 (2005) 794-799
23. Katayama A., Bandoh N., Kishibe K., et al. Expressions of matrix metalloproteinases in early-stage oral squamous cell carcinoma as predictive indicators for tumor metastases and prognosis. Clin Cancer Res 10 2 (2004) 634-640
24. Barnes L., Eveson J.W., Reichart P., and Sidransky D. World Health Organization classification of tumours. Pathology and genetics of head and neck tumours (2005), IARC Press, Lyon, France
25. Garber K. Energy boost: the Warburg effect returns in a new theory of cancer. J Natl Cancer Inst 96 24 (2004) 1805-1806
26. Warburg O. On the origin of cancer cells. Science 123 3191 (1956) 309-314
27. Keen H.G., Dekker B.A., Disley L., et al. Imaging apoptosis in vivo using 124I-annexin V and PET. Nucl Med Biol 32 4 (2005) 395-402
28. Soret M., Bacharach S.L., and Buvat I. Partial-volume effect in PET tumor imaging. J Nucl Med 48 6 (2007) 932-945